🇺🇸 FDA
Patent

US 10220002

Controlled-release peptide compositions and uses thereof

granted A61KA61K2039/505A61K38/08

Quick answer

US patent 10220002 (Controlled-release peptide compositions and uses thereof) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/505, A61K38/08, A61K38/1725, A61K39/0005